A global leader in medical technologies, Australia offers investment opportunities ranging from discovery research through to product development partnerships in biotech, pharmaceuticals, medical devices, tropical medicines and digital health areas. Investors can benefit from:

  • research excellence and a collaborative culture
  • accessible world-class research infrastructure
  • a track record of commercial success
  • an ideal market for testing new innovative medical products/technologies
  • Australia’s trade, investment and cultural ties to the fast-growing Asia-Pacific region.

Australia has a strong but flexible regulatory regime including strong intellectual property (IP) protection, fast-tracked clinical trials, tax incentives and a supportive business culture for undertaking research and development (R&D).


Investor Update

29 Nov 2019

Japan’s biggest pharma co., Takeda, teams with Melbourne’s BioCurate to expedite new drug development

Click through to news item